World Malayalee Pharma

Tag: Paragraph IV certification

FDA's 180-Day Exclusivity: How First Generic Applicants Gain Market Advantage

FDA's 180-Day Exclusivity: How First Generic Applicants Gain Market Advantage

Maddie Shepherd Dec 8 10 Comments

FDA's 180-day exclusivity gives the first generic drug applicant a head start on the market, but it's often used to delay competition. Learn how it works, who benefits, and why reforms are coming.

More Detail

Recent posts

How to Report a Pharmacy Error and What Happens Next
How to Report a Pharmacy Error and What Happens Next

December 15 2025

Generic vs. Brand Name Drugs: What You Really Need to Know About Bioequivalence and Savings
Generic vs. Brand Name Drugs: What You Really Need to Know About Bioequivalence and Savings

December 19 2025

Medication Errors with Generics: Look-Alike, Sound-Alike Risks and How to Stop Them
Medication Errors with Generics: Look-Alike, Sound-Alike Risks and How to Stop Them

November 29 2025

From ANDA to Shelf: How Generic Drugs Reach Retail Pharmacies
From ANDA to Shelf: How Generic Drugs Reach Retail Pharmacies

January 31 2026

How to Get 90-Day Fills to Lower Prescription Costs
How to Get 90-Day Fills to Lower Prescription Costs

November 27 2025

Tags

online pharmacy
generic drugs
Hatch-Waxman Act
medication safety
medication side effects
drug safety
dosage
cardiovascular risk
patient safety
therapeutic equivalence
blood sugar support
online pharmacy safety
antibiotics
insulin resistance
smoking
heart disease
maternal mental health
gut health
minoxidil
hair loss treatment

About Us

Health

bg-footer

About Us

Health

Menu
About Terms Privacy Policy GDPR Compliance Contact Us
© 2026. All rights reserved.